NCT03459911View on ClinicalTrials.gov

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 16, 2018

Primary Completion Date

March 11, 2018

Study Completion Date

March 16, 2018

Conditions

Healthy

Interventions

DRUG

Cozaar 100mg Tablet

Cozaar® ( Losartan potassium) 100 mg Tablets(Merck Sharpe \& Dohme B.V. , Haarlem, the Netherlands)

DRUG

Losartan potassium 100mg

Losartan potassium 100 mg Tablets ( Pharmtechnology LLC, Republic of Belarus)

Trial Locations (1)

400 701

Clinical Unit, Reliance Life Sciences Pvt. Ltd., Mumbai

All Listed Sponsors

collaborator

Reliance Life Sciences Private Limited

INDUSTRY

lead

Pharmtechnology LLC

INDUSTRY

NCT03459911 - A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions | Biotech Hunter | Biotech Hunter